GENUS FDA Approval ANDA 040894

ANDA 040894

GENUS

FDA Drug Application

Application #040894

Application Sponsors

ANDA 040894GENUS

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL325MG/15ML;7.5MG/15ML0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE

FDA Submissions

ORIG1AP2011-07-19
LABELING; LabelingSUPPL2AP2016-01-05STANDARD
LABELING; LabelingSUPPL5AP2016-12-16STANDARD
LABELING; LabelingSUPPL6AP2016-12-16STANDARD
LABELING; LabelingSUPPL9AP2016-12-16STANDARD
REMS; REMSSUPPL10AP2018-09-18STANDARD
LABELING; LabelingSUPPL11AP2018-09-21STANDARD
LABELING; LabelingSUPPL12AP2019-10-07STANDARD
LABELING; LabelingSUPPL16AP2021-03-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2022-04-20STANDARD

Submissions Property Types

ORIG1Null42
SUPPL2Null7
SUPPL5Null15
SUPPL6Null15
SUPPL9Null7
SUPPL10Null15
SUPPL11Null15
SUPPL12Null15
SUPPL16Null7
SUPPL21Null7

TE Codes

001PrescriptionAA

CDER Filings

GENUS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40894
            [companyName] => GENUS
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"325MG\/15ML;7.5MG\/15ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","submission":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","actionType":"325MG\/15ML;7.5MG\/15ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.